Bendamustine and Melphalan in Myeloma
Clinical trial NCT03187223 · COMPLETED
Trial details
- NCT number
- NCT03187223
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-20
- Primary completion
- 2020-03-12
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.